$260 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 54 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 56.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Sell | Celgene Corp | $15,050,000 | -17.9% | 189,522 | -7.8% | 5.78% | -19.2% |
| ARRY | Sell | Array Biopharma Inc | $11,647,000 | -16.1% | 694,500 | -18.4% | 4.47% | -17.5% |
| REGN | Sell | Regeneron Pharmaceuticals | $10,808,000 | -12.9% | 31,330 | -13.0% | 4.15% | -14.3% |
| BIIB | Sell | Biogen Inc | $10,510,000 | -15.8% | 36,208 | -20.6% | 4.04% | -17.1% |
| LGND | Sell | Ligand Pharmaceuticals Inc | $7,250,000 | +4.5% | 35,000 | -16.7% | 2.78% | +2.9% |
| SAGE | Sell | Sage Therapeutics Inc | $6,726,000 | -40.7% | 42,996 | -39.0% | 2.58% | -41.6% |
| GILD | Sell | Gilead Sciences Inc | $6,397,000 | -35.4% | 90,284 | -31.2% | 2.46% | -36.4% |
| SHPG | Sell | Shire plcsponsored adr | $4,220,000 | -71.5% | 25,000 | -74.7% | 1.62% | -71.9% |
| GTHX | Sell | G1 Therapeutics Inc | $3,121,000 | -18.1% | 72,000 | -30.1% | 1.20% | -19.4% |
| JAZZ | Sell | Jazz Pharmaceuticals PLC | $2,791,000 | -2.7% | 16,200 | -14.7% | 1.07% | -4.1% |
| RSLS | Sell | ReShape Lifesciences Inc | $121,000 | -89.4% | 52,546 | -93.3% | 0.05% | -89.7% |
| FOMX | Exit | Foamix Pharmaceuticals Ltd | $0 | – | -63,202 | -100.0% | -0.13% | – |
| ESPR | Exit | Esperion Therapeutics Inc | $0 | – | -10,000 | -100.0% | -0.28% | – |
| ANAB | Exit | Anaptysbio Inc | $0 | – | -8,500 | -100.0% | -0.34% | – |
| ACAD | Exit | Acadia Pharmaceuticals Inc | $0 | – | -42,773 | -100.0% | -0.38% | – |
| TSRO | Exit | Tesaro Inc | $0 | – | -21,300 | -100.0% | -0.48% | – |
| OPTN | Exit | Optinose Inc | $0 | – | -65,000 | -100.0% | -0.51% | – |
| BGNE | Exit | BeiGene Ltdsponsored adr | $0 | – | -9,500 | -100.0% | -0.62% | – |
| PEN | Exit | Penumbra Inc | $0 | – | -14,000 | -100.0% | -0.63% | – |
| AXGN | Exit | Axogen Inc | $0 | – | -50,000 | -100.0% | -0.71% | – |
| MTEM | Exit | Molecular Templates Inc | $0 | – | -247,587 | -100.0% | -0.77% | – |
| RARE | Exit | Ultragenyx Pharmaceutical Inc | $0 | – | -41,000 | -100.0% | -0.82% | – |
| AVXS | Exit | Avexis Inc | $0 | – | -17,000 | -100.0% | -0.82% | – |
| SGYPQ | Exit | Synergy Pharmaceuticals DEL | $0 | – | -1,505,809 | -100.0% | -1.06% | – |
| CLVS | Exit | Clovis Oncology Inc | $0 | – | -76,000 | -100.0% | -1.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.